Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An osteosarcoma arising from the breast tissue.
Biomarker and diagnostic research for breast extraskeletal osteosarcoma has been reported in the published literature.
No clinical trials have been registered for breast extraskeletal osteosarcoma.
60 publications have been identified in PubMed for breast extraskeletal osteosarcoma. Research spans Basic Science / Preclinical (45%), Review / Meta-Analysis (22%), and Case Report / Case Series (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 27 | 45% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Common questions about breast extraskeletal osteosarcoma
Research summaries
13 |
22% |
Patient case studies | 12 | 20% |
Disease patterns and progression | 3 | 5% |
New treatment approaches | 3 | 5% |
Testing and diagnosis research | 1 | 2% |
Clinical study results | 1 | 2% |
Traub F (2026). [PMID: 41799501](https://pubmed.ncbi.nlm.nih.gov/41799501/). *Oncology research*. [Case Report / Case Series]
Xu W (2026). [PMID: 41791304](https://pubmed.ncbi.nlm.nih.gov/41791304/). *International immunopharmacology*. [Basic Science / Preclinical]
Kwieciński M (2026). [PMID: 42133114](https://pubmed.ncbi.nlm.nih.gov/42133114/). *Mol Biol Rep*. [Review / Meta-Analysis]
Luo Y (2026). [PMID: 41685588](https://pubmed.ncbi.nlm.nih.gov/41685588/). *International journal of oncology*. [Basic Science / Preclinical]
Raslan MA (2026). [PMID: 41895184](https://pubmed.ncbi.nlm.nih.gov/41895184/). *Journal of chromatography. B, Analytical technologies in the biomedical and life sciences*. [Gene Therapy / Novel Therapeutics]
Sun Y (2026). [PMID: 41939465](https://pubmed.ncbi.nlm.nih.gov/41939465/). *Frontiers in oncology*. [Case Report / Case Series]
Elemam NM (2026). [PMID: 41771457](https://pubmed.ncbi.nlm.nih.gov/41771457/). *Critical reviews in oncology/hematology*. [Basic Science / Preclinical]
Li X (2026). [PMID: 41522606](https://pubmed.ncbi.nlm.nih.gov/41522606/). *Research (Washington, D.C.)*. [Clinical Trial Publication]
Akladios C (2026). [PMID: 41407107](https://pubmed.ncbi.nlm.nih.gov/41407107/). *Journal of gynecology obstetrics and human reproduction*. [Review / Meta-Analysis]
Kim DJ (2026). [PMID: 41596524](https://pubmed.ncbi.nlm.nih.gov/41596524/). *International journal of molecular sciences*. [Review / Meta-Analysis]